BROWSE·page 495 of 1507

Browse EX-10 agreements

18,081 total material contract exhibits.


EXHIBIT 10.1

Outlook Therapeutics, Inc.

EXECUTIVE EMPLOYMENT AGREEMENT

This Executive Employment Agreement (this “Agreement”) effective as of September 1, 2026 (“Effective Date”) is entered into between Outlook Therapeutics, Inc., a Delaware corporation with its principal place of business at 111 S. Wood, Avenue, Unit #100, Iselin, New Jersey 08830 (the “Company”) and Kevin Lundquist, residing at [intentionally redacted](the “Executive”).

In consideration of the promises and the terms and conditions set forth in this Agreement, the parties agree as follows:

…

EX-10.1·8-K·CIK 1649989·ACC 0001104659-26-102446·Filed Aug 27, 2026, 16:11 ET

EXHIBIT 10.2

Outlook Therapeutics, Inc.

August 27, 2026

Lawrence A. Kenyon

Dear Larry:

In accordance with the Amended and Restated Executive Employment Agreement, dated as of June 2, 2022 (“Employment Agreement”), entered into between you and Outlook Therapeutics, Inc. (the “Company”), this letter sets out the substance of the separation agreement (the “Agreement”) that the Company is offering you to aid in your employment transition. Any capitalized terms in this Separation Agreement will take their meaning from the Employment Agreement unless otherwise defined herein.

…

EX-10.2·8-K·CIK 1649989·ACC 0001104659-26-102446·Filed Aug 27, 2026, 16:11 ET

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

** **

PROMISSORY NOTE

** **

Principal Amount: US$500,000

Dated: August 25, 2026

New York, New York

…

EX-10.1·8-K·CIK 2024459·ACC 0001213900-26-094383·Filed Aug 27, 2026, 16:10 ET

EX-10.3

Ulta Beauty, Inc.

ULTA BEAUTY, INC.

2026 INCENTIVE AWARD PLAN

OPTION AGREEMENT - CERTIFICATE

The following (this “Award Agreement”) evidences the grant of an option (the “Option”) to purchase Shares of Ulta Beauty, Inc. (the “Company”) pursuant to the Ulta Beauty, Inc. 2026 Incentive Award Plan (the “Plan”) to the following individual (the “Optionee”) and upon the following terms:  

Optionee: Name**: Address: **​Location-
Grant Date: ​
Exercise Price Per Share: ​
Total Number of Options Granted: ​
Type of Option: ​

…

EX-10.3·10-Q·CIK 1403568·ACC 0001104659-26-102442·Filed Aug 27, 2026, 16:09 ET

EX-10.2

Ulta Beauty, Inc.

ULTA BEAUTY, INC.

2026 INCENTIVE AWARD PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT

Ulta Beauty, Inc. (the “Company”), pursuant to the Ulta Beauty, Inc. 2026 Incentive Award Plan (the “Plan”), hereby grants the number of Restricted Stock Units (each, an “RSU”) set forth below to the following individual (the “Holder”), subject to the restrictions on transfer and forfeiture and such other limitations set forth herein and in the Plan. Each RSU entitles the Holder to receive an equal number of Shares at settlement, as described herein.

**Name:**​ **Address:**​
**Grant Date ** ​
Total Number of RSUs Granted ​

Unless otherwise defined herein, capitalized terms used in this agreement (this “Award Agreement”) shall have the same meanings set forth in the Plan.

…

EX-10.2·10-Q·CIK 1403568·ACC 0001104659-26-102442·Filed Aug 27, 2026, 16:09 ET

EX-10.1 CIC AGREEMENT - MAINGOT

NATIONAL HEALTH INVESTORS INC

CHANGE IN CONTROL SEVERANCE AGREEMENT

THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Agreement”) is entered into as of August 27, 2026 (the “Effective Date”), by and between National Health Investors, Inc., a Maryland corporation (the “Company”) and Christian Maingot (the “Executive”).

W I T N E S S E T H

WHEREAS, the Committee (as defined in Section 1) has determined that it is in the best interests of the Company and its stockholders to secure the Executive’s continued services and objectivity in the event of any threat or occurrence of, or negotiation or other action that could lead to, or create the possibility of, a Change in Control (as defined in Section 1) of the Company, without concern as to whether the Executive might be hindered or distracted by personal uncertainties and risks created by any such possible Change in Control, and to encourage the Executive’s full attention and dedication to the Company, and in order to further such interests, the Committee has authorized the Company to enter into this Agreement.

…

EX-10.1·8-K·CIK 877860·ACC 0000877860-26-000205·Filed Aug 27, 2026, 16:08 ET

EX-10.4

PagerDuty, Inc.

PagerDuty, Inc.

600 Townsend Street, Suite 200

San Francisco, CA 94103

June 4, 2026

Dear Eric Prengel,

On behalf of PagerDuty, Inc., a Delaware corporation (the “Company”), I am pleased to offer you the position of Chief Financial Officer of the Company, subject to your formal appointment by the Board of Directors. We believe that you will add substantially to the team and contribute greatly to the ultimate success of the Company by providing the Company with the same extraordinary leadership and vision that you have demonstrated throughout your career. The existing PagerDuty team and I look forward to your help in building PagerDuty into a great company.

We understand and appreciate the nature of the commitment you are making to join the Company, and we want you to do so with great confidence. You have the qualities that distinguish successful executives: leadership, vision, high integrity, intelligence, a bias to action, and a desire to make a difference. We are extremely enthusiastic about your accepting this offer.

…

EX-10.4·10-Q·CIK 1568100·ACC 0001568100-26-000045·Filed Aug 27, 2026, 16:08 ET

NPH SETTLEMENT AND MUTUAL RELEASE AGREEMENT

BION ENVIRONMENTAL TECHNOLOGIES INC

SETTLEMENT AND MUTUAL RELEASE AGREEMENT

This Settlement and Mutual Release Agreement ("Settlement Agreement") is entered into by and between BION ENVIRONMENTAL TECHNOLOGIES, INC. ("BION"), BION TECHNOLOGIES, INC. ("BION TECH"), BION 3G-1 LLC ("3G-1"), (from time to time collectively referred to as “Bion” or "Bion Group"), and NORTH PRAIRIE HOLDINGS, LLC ("NPH"). The parties to this Settlement Agreement are referred to herein from time to time as the "Parties," or each singularly, as a "Party." The "Effective Date" is August 25, 2026.

Recitals

WHEREAS, BION TECH and 3G-1 are subsidiaries and/or affiliates of BION.

WHEREAS, NPH is owner of approximately 20 acres of real property located at 5093 East 700 North, Fair Oaks, Newton County, Indiana (the "Property").

…

EX-10.1·8-K·CIK 875729·ACC 0001079973-26-001186·Filed Aug 27, 2026, 16:06 ET

NPH CONVERTIBLE PROMISSORY NOTE

BION ENVIRONMENTAL TECHNOLOGIES INC

THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES IN THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.

CONVERTIBLE PROMISSORY NOTE

Date of Note: August 25, 2026

Initial Principal Amount: $162,500.00

…

EX-10.2·8-K·CIK 875729·ACC 0001079973-26-001186·Filed Aug 27, 2026, 16:06 ET

EX-10.11

Lifevantage Corp

--

714508044v4

Exhibit 10.11

AMENDMENTNO.1TOLOANAGREEMENTANDCONSENT

This Amendment No. 1 to Loan Agreement and Consent (the “Amendment”), dated as of September22, 2025, is between Bank of America, N.A. (the “Bank”) and LifeVantage Corporation, a Delaware corporation (the “Borrower”).

RECITALS

A.

The Bank and the Borrower entered into a certain Loan Agreement dated as of April12, 2024 (together with any previous amendments or supplements thereto, the “Loan Agreement”).

B.

…

EX-10.11·10-K·CIK 849146·ACC 0001193125-26-371257·Filed Aug 27, 2026, 16:05 ET

EX-10.17

Lifevantage Corp

CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL, AND HAS BEEN MARKED WITH

“[***]” TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.

KEYEXECUTIVEBENEFITSAGREEMENT

LifeVantage Corporation (the "Company") has established this Key Executive Benefits Agreement (the "Agreement") to attract, motivate and retain certain key executives of the Company. An employee is considered a Key Executive upon approval by the Company's Compensation Committee. You shall be considered a Key Executive of the Company. This Agreement is entered into between the Company and Terrence Moorehead (“Key Executive” or “you”) effective as ofAugust 5, 2026.

ThetermsandconditionsofthisAgreementareasfollows:

1.

PositionandResponsibilities.

a.

…

EX-10.17·10-K·CIK 849146·ACC 0001193125-26-371257·Filed Aug 27, 2026, 16:05 ET

EMPLOYMENT AGREEMENT

EMPLOYMENT AGREEMENT (this “Agreement”), dated as of March 28, 2026, between Terra Innovatum Corp. (the “Company”) and Katherine Williams (“Executive,” together with the Company, the “Parties” and, each, a “Party”).

WHEREAS, the Company desires to employ Executive, and Executive desires to accept such employment, on the terms and conditions set forth in this Agreement;

NOW, THEREFORE, on the basis of the foregoing premises and in consideration of the mutual covenants and agreements contained herein, the Parties agree as follows:

…

EX-10.1·8-K·CIK 2067627·ACC 0001213900-26-094377·Filed Aug 27, 2026, 16:05 ET